Severe COVID-19 or flu infections silently reprogram your lungs’ immune defenses, potentially sparking cancer years later—even if you never smoked.
Story Snapshot
- UVA research shows severe cases raise lung cancer risk 1.24-fold through lasting immune inflammation.
- Vaccines prevent severe infections, slashing this hidden cancer threat indirectly.
- Only hospitalized cases elevate risk; mild infections slightly lower it.
- Neutrophils and macrophages turn pro-tumor, mimicking chronic damage without smoking.
- Experts urge CT scans for survivors, like screening smokers.
Research Uncovers Viral Reprogramming Mechanism
University of Virginia scientists at the Beirne B. Carter Center for Immunology Research and UVA Comprehensive Cancer Center studied mice and human data. Severe COVID-19 or influenza triggered neutrophils and macrophages to create pro-tumor environments. These immune cells fostered chronic inflammation in lung air sacs. Epithelial cells underwent lasting changes, independent of smoking or other conditions. Human hospitalization records confirmed a 1.24-fold cancer risk increase months or years post-infection.
Lead Researchers Drive New Insights
Jie Sun, Ph.D., co-director at the Carter Center, led the effort to link post-viral effects to oncology. His team modeled severe pneumonia in mice, observing higher cancer rates and mortality. Jeffrey Sturek, MD, Ph.D., collaborated, analyzing patient outcomes. They published findings in the journal Cell around March 2026. Sun stated vaccination largely prevents these harmful immune changes. Sturek recommended CT screening for severe cases, equating viral damage to smoking history.
Historical Precedents and Pandemic Context
Respiratory viruses have caused lung injury for decades, with flu seasons stressing lungs routinely. The COVID-19 pandemic from 2020 left tens of millions with pulmonary issues worldwide. Chronic conditions like tuberculosis previously hinted at cancer links through inflammation. This UVA study breaks new ground by pinpointing acute viral pneumonia’s role in immune scarring. U.S. data drives findings, but global infection scales amplify implications, especially for smokers.
Distinct Risk Profile Emerges
Severe hospitalized cases alone drive the elevated risk, unlike mild infections that slightly reduce it. Vaccines protect by averting hospitalization, offering indirect cancer prevention grounded in common sense. No evidence contradicts the peer-reviewed mouse and associative human data. Longitudinal studies will confirm causation, but current evidence demands action.
News coverage hit March 11-12, 2026, across outlets like WTOP and Medical Xpress.
Implications Demand Action
Short-term, severe survivors need immediate CT scans, particularly smokers. Long-term, oncology guidelines must incorporate this risk factor amid rising cases. Healthcare systems face screening demands, with economic costs for scans and treatments. Public health shifts toward post-viral surveillance. Pharma benefits as vaccines prove protective. This research validates proactive measures over reaction.
Sources:
Severe COVID-19 or Flu Raises Risk of Lung Cancer, Even Years Later: U.Va. Research Finds
Severe COVID-19 or flu raises risk of lung cancer, even years later: U.Va. research finds
Severe COVID-19 and flu can facilitate lung cancer months or years later
Severe COVID or Flu May Raise Lung Cancer Risk Years Later
Severe COVID or Severe Flu May Raise Risk of Lung Cancer—But Vaccines Helped in Animal Tests
